Epidemiological and biochemical aspects of progression in multiple sclerosis

Marcus Werner Koch

Research output: ThesisThesis fully internal (DIV)

106 Downloads (Pure)


Patients with a progressive form of multiple sclerosis have the worst prognosis. They can expect that their symptoms will steadily worsen, and there is currently no treatment that has a proven effect on progressive multiple sclerosis. The underlying pathophysiology of the progressive forms of multiple sclerosis appears to be distinct from that of the relapsing-remitting form. Research on multiple sclerosis has largely been focussed on the relapsing-remitting form of the disease, while there is relatively little knowledge of the progressive forms of MS. In this thesis, we aimed to investigate epidemiological and biochemical factors associated with progression in MS.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • University of Groningen
  • de Keyser, J.H.A., Supervisor
Award date16-Jan-2008
Print ISBNs9789036732871
Publication statusPublished - 2008


  • Multiple sclerose, Epidemiologie , Biochemie Proefschriften
  • neurologie

Cite this